![António Bernadino Guimaraes Parada](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
António Bernadino Guimaraes Parada
Vorstandsvorsitzender bei IONTAS Ltd. (United Kingdom)
Profil
António Bernadino Guimaraes Parada is the founder of Fairjourney Biologics SA, where he holds the position of Chairman & Chief Executive Officer since 2012.
He is also the founder of Biocodex Incubação de Empresas de Ciências da Vida SA. Currently, he is the Chief Executive Officer at IONTAS Ltd.
(United Kingdom) since 2020.
Aktive Positionen von António Bernadino Guimaraes Parada
Unternehmen | Position | Beginn |
---|---|---|
IONTAS Ltd. (United Kingdom)
![]() IONTAS Ltd. (United Kingdom) BiotechnologyHealth Technology Part of Fairjourney Biologics SA, IONTAS Ltd. is a British company that provides antibody discovery services. The company is based in Cambridge, UK. The company was founded by John McCafferty. António Bernadino Guimaraes Parada has been the CEO of the company since 2020. IONTAS Ltd. (United Kingdom) was acquired by Fairjourney Biologics SA on May 13, 2020. | Vorstandsvorsitzender | 01.05.2020 |
Fairjourney Biologics SA
![]() Fairjourney Biologics SA BiotechnologyHealth Technology Fairjourney Biologics SA is a biologics contract research organization that provides integrated services across antibody discovery, engineering, and production to biopharma. The Portuguese company operates a flexible, customer-oriented ‘ one-stop shop ’ approach to biologics development focused on quality, reliability, and partnership. Fairjourney Biologics has successfully completed more than 500 projects for over 100 customers across big pharma and leading biotech companies to date. The company's innovative mammalian display platform enables full-length antibodies to be expressed in the context of a mammalian cell, allowing selection based on function, stability, expression, and developability. The company has grown to over 130 highly technically skilled employees today and has subsidiaries in the United Kingdom. Fairjourney Biologics was founded in 2012 by António Bernadino Guimaraes Parada and Maria Gonzalez Pajuelo and is headquartered in Porto, PT. António Bernadino Guimaraes Parada has been the CEO since 2012. | Vorstandsvorsitzender | 01.01.2012 |
Ehemalige bekannte Positionen von António Bernadino Guimaraes Parada
Unternehmen | Position | Ende |
---|---|---|
Biocodex Incubação de Empresas de Ciências da Vida SA
![]() Biocodex Incubação de Empresas de Ciências da Vida SA Financial ConglomeratesFinance Biocodex Incubação de Empresas de Ciências da Vida SA invests in and develops biotechnology research businesses and programs. The company was founded on July 29, 2002 and is headquartered in Porto, Portugal. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Biocodex Incubação de Empresas de Ciências da Vida SA
![]() Biocodex Incubação de Empresas de Ciências da Vida SA Financial ConglomeratesFinance Biocodex Incubação de Empresas de Ciências da Vida SA invests in and develops biotechnology research businesses and programs. The company was founded on July 29, 2002 and is headquartered in Porto, Portugal. | Finance |
IONTAS Ltd. (United Kingdom)
![]() IONTAS Ltd. (United Kingdom) BiotechnologyHealth Technology Part of Fairjourney Biologics SA, IONTAS Ltd. is a British company that provides antibody discovery services. The company is based in Cambridge, UK. The company was founded by John McCafferty. António Bernadino Guimaraes Parada has been the CEO of the company since 2020. IONTAS Ltd. (United Kingdom) was acquired by Fairjourney Biologics SA on May 13, 2020. | Health Technology |
Fairjourney Biologics SA
![]() Fairjourney Biologics SA BiotechnologyHealth Technology Fairjourney Biologics SA is a biologics contract research organization that provides integrated services across antibody discovery, engineering, and production to biopharma. The Portuguese company operates a flexible, customer-oriented ‘ one-stop shop ’ approach to biologics development focused on quality, reliability, and partnership. Fairjourney Biologics has successfully completed more than 500 projects for over 100 customers across big pharma and leading biotech companies to date. The company's innovative mammalian display platform enables full-length antibodies to be expressed in the context of a mammalian cell, allowing selection based on function, stability, expression, and developability. The company has grown to over 130 highly technically skilled employees today and has subsidiaries in the United Kingdom. Fairjourney Biologics was founded in 2012 by António Bernadino Guimaraes Parada and Maria Gonzalez Pajuelo and is headquartered in Porto, PT. António Bernadino Guimaraes Parada has been the CEO since 2012. | Health Technology |